THE WOODLANDS, TX - Autonomix Medical, Inc. (NASDAQ: AMIX), a company specializing in medical device technology for nervous system diseases, announced the appointment of Jennifer Cook as its new Chief Business Officer. Mrs. Cook brings extensive experience in building businesses and brands in consumer and medical technology sectors.
Jennifer Cook's career spans 28 years, during which she has been instrumental in developing and executing business strategies for early developmental stage companies. Her most recent role was Vice President of Marketing at MedShift, and she played a key role in Soliton (NASDAQ:SOLY), Inc.'s brand and commercial strategy, leading to its acquisition by AbbVie (NYSE:ABBV).
Lori Bisson, CEO of Autonomix, expressed confidence in Cook's ability to contribute to the company's growth, citing her track record in establishing global positioning and competitive brand strategy. Cook will now be part of a leadership team tasked with advancing Autonomix's technology platform, which includes a microchip sensing array for diagnosing and treating peripheral nervous system diseases.
Autonomix is currently focusing on developing its technology to address pancreatic cancer pain. The company's innovative approach has the potential to be applied to various medical conditions, including cardiology and chronic pain management.
The information in this article is based on a press release statement from Autonomix Medical, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.